Vet Med - Czech, 2026, 71(8):337-347 | DOI: 10.17221/8/2026-VETMED

Effects of vitamins A and E on eprinomectin transport in Caco-2 cellsOriginal Paper

Y Gunes ORCID...1, Y Gultekin ORCID...2, O Dogan ORCID...3,4, C Anlas ORCID...1, O Ustuner ORCID...1, N Yilmaz ORCID...1, T Bakirel ORCID...1
1 Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye
2 Department of Pharmaceutical Technology, Faculty of Pharmacy, Selcuk University, Konya, Turkiye
3 Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye
4 Department of Pharmaceutical Technology, Faculty of Pharmacy, Baskent University, Ankara, Turkiye

Eprinomectin (EPR) is a macrocyclic lactone antiparasitic widely used in veterinary medicine. Although the off-label oral use of the pour-on formulation of EPR is known to be effective and practical, data regarding its interactions with foods or vitamin supplements that may affect intestinal absorption remain limited. This study investigated the effects of vitamin A (VA) and vitamin E (VE) on the transepithelial permeability of EPR using the Caco-2 cell monolayer model. An analytical method for EPR quantification was developed using ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). The integrity of tight junction dynamics in epithelial monolayers was monitored using transepithelial electrical resistance (TEER) throughout the 21-day differentiation protocol. Apparent permeability coefficients (Papp) were calculated in both apical-to-basolateral and basolateral-to-apical directions and compared between EPR alone and EPR combined with the vitamins. EPR alone exhibited moderate permeability across Caco-2 monolayers (7.64 ± 2.27 × 10–6 cm/s). Notably, our results demonstrate that co-treatment of EPR with VA alone, as well as co-treatment with the combination of VA and VE, significantly reduced EPR permeability in vitro (P < 0.001). These findings highlight possible food/nutrient-drug interactions relevant to veterinary oral drug administration, and additional mechanistic and in vivo studies will be necessary to clarify the underlying pathways.

Keywords: Caco-2 transwell model; eprinomectin; fat-soluble vitamins; intestinal permeability; P-glycoprotein

Received: February 19, 2026; Revised: May 13, 2026; Accepted: May 18, 2026; Prepublished online: August 21, 2026; Published: August 23, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gunes Y, Gultekin Y, Dogan O, Anlas C, Ustuner O, Yilmaz N, Bakirel T. Effects of vitamins A and E on eprinomectin transport in Caco-2 cells. Veterinární medicína. 2026;71(8):337-347. doi: 10.17221/8/2026-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5. Go to original source...
    2. Atkinson J, Marquardt D, DiPasquale M, Harroun T. From fat to bilayers: Understanding where and how vitamin E works. Free Radic Biol Med. 2021 Nov 20;176:73-9. Go to original source... Go to PubMed...
    3. Awortwe C, Fasinu PS, Rosenkranz B. Application of Caco-2 cell line in herb-drug interaction studies: Current approaches and challenges. J Pharm Pharm Sci. 2014;17(1):1-19. Go to original source...
    4. Badie C, Lespine A, Devos J, Sutra JF, Chartier C. Kinetics and anthelmintic efficacy of topical eprinomectin when given orally to goats. Vet Parasitol. 2015 Apr 15;209(1-2):56-61. Go to original source... Go to PubMed...
    5. Berginc K, Zakelj S, Kristl A. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients. Eur J Nutr. 2010 Sep;49(6):373-84. Go to original source... Go to PubMed...
    6. Bjerke DL, Li R, Price JM, Dobson RLM, Rodrigues M, Tey C, Vires L, Adams RL, Sherrill JD, Styczynski PB, Goncalves K, Maltman V, Przyborski S, Oblong JE. The vitamin A ester retinyl propionate has a unique metabolic profile and higher retinoid-related bioactivity over retinol and retinyl palmitate in human skin models. Exp Dermatol. 2021 Feb;30(2):226-36. Go to original source... Go to PubMed...
    7. Bordes L, Ticoulet D, Sutra JF, Lespine A, Jacquiet P. Lack of efficacy of topical administration of eprinomectin against gastrointestinal nematode in a French dairy sheep farm: A case of underexposure of worms. Vet Rec Case Rep. 2022 Jul;10(4):e435. Go to original source...
    8. Campbell WC. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Curr Pharm Biotechnol. 2012 May;13(6):853-65. Go to original source... Go to PubMed...
    9. Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, Schaefer UF, Lehr CM. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release. 2006 Mar 10;111(1-2):35-40. Go to original source... Go to PubMed...
    10. Davis S, Davis BM, Richens JL, Vere KA, Petrov PG, Winlove CP, O'Shea P. alpha-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein. J Lipid Res. 2015 Aug;56(8):1543-50. Go to original source... Go to PubMed...
    11. DeHaven WI, Conner DP. The effects of food on drug bioavailability and bioequivalence. In: Yu LX, Li BV, editors. FDA bioequivalence standards. New York (NY): Springer; 2014. p. 95-118. Go to original source...
    12. During A, Harrison EH. Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells. J Lipid Res. 2007;48(10):2283-94. Go to original source... Go to PubMed...
    13. EFSA. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Scientific opinion on the safety and efficacy of vitamin E as a feed additive for all animal species. EFSA J. 2010 May;8(6):1635. Go to original source... Go to PubMed...
    14. EFSA. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Scientific opinion on the safety and efficacy of vitamin A (retinyl acetate, retinyl palmitate and retinyl propionate) as a feed additive for all animal species and categories. EFSA J. 2013 Jan;11(1):3037. Go to original source...
    15. Escriba PV, Gonzalez-Ros JM, Goni FM, Kinnunen PK, Vigh L, Sanchez-Magraner L, Fernandez AM, Busquets X, Horvath I, Barcelo-Coblijn G. Membranes: A meeting point for lipids, proteins and therapies. J Cell Mol Med. 2008 Jun;12(3):829-75. Go to original source... Go to PubMed...
    16. EMEA. European Agency for the Evaluation of Medicinal Products, Veterinary Medicines Evaluation Unit. Eprinomectin: Summary report (1). EMEA/MRL/114/96-FINAL. London: EMEA; 1996.
    17. Finno CJ. Veterinary pet supplements and nutraceuticals. Nutr Today. 2020 Mar-Apr;55(2):97-101. Go to original source... Go to PubMed...
    18. Geary TG, Moreno Y. Macrocyclic lactone anthelmintics: Spectrum of activity and mechanism of action. Curr Pharm Biotechnol. 2012 May;13(6):866-72. Go to original source... Go to PubMed...
    19. Geyer J, Doring B, Godoy JR, Leidolf R, Moritz A, Petzinger E. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany. J Vet Pharmacol Ther. 2005 Dec;28(6):545-51. Go to original source...
    20. Gokbulut C, Di Loria A, Gunay N, Masucci R, Veneziano V. Plasma disposition, concentration in the hair, and anthelmintic efficacy of eprinomectin after topical administration in donkeys. Am J Vet Res. 2011 Dec;72(12):1639-45. Go to original source... Go to PubMed...
    21. Gunes Y, Blanco-Paniagua E, Anlas C, Sari AB, Bakirel T, Ustuner O, Merino G. Role of the Abcg2 transporter in plasma, milk, and tissue levels of the anthelmintic monepantel in mice. Chem Biol Interact. 2024 Aug 1;398:111117. Go to original source... Go to PubMed...
    22. Hamel D, Visser M, Mayr S, Rauh R, Wang H, Fankhauser R, Rehbein S. Eprinomectin pour-on: Prevention of gastrointestinal and pulmonary nematode infections in sheep. Vet Parasitol. 2018 Dec 15;264:42-6. Go to original source... Go to PubMed...
    23. Han Y, Tan TM, Lim LY. Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol. 2006 Jun 14;71(12):1727-34. Go to original source... Go to PubMed...
    24. Herr FM, Li E, Weinberg RB, Cook VR, Storch J. Differential mechanisms of retinoid transfer from cellular retinol binding proteins types I and II to phospholipid membranes. J Biol Chem. 1999 Apr 2;274(14):9556-63. Go to original source...
    25. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989 Mar;96(3):736-49. Go to original source...
    26. Hinney B, Wiedermann S, Kaiser W, Krucken J, Joachim A. Eprinomectin and moxidectin resistance of trichostrongyloids on a goat farm in Austria. Pathogens. 2022 Apr 21;11(5):498. Go to original source... Go to PubMed...
    27. Husain A, Makadia V, Valicherla GR, Riyazuddin M, Gayen JR. Approaches to minimize the effects of P-glycoprotein in drug transport: A review. Drug Dev Res. 2022 Jun;83(4):825-41. Go to original source...
    28. ICH. International Council for Harmonisation. ICH harmonised tripartite guideline: Validation of analytical procedures: Text and methodology Q2(R1). Geneva: ICH; 1996.
    29. ICH. International Council for Harmonisation. ICH harmonised guideline: Biopharmaceutics classification system-based biowaivers M9. Geneva: ICH; 2019.
    30. International Transporter Consortium; Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. Membrane transporters in drug development. Nat Rev Drug Discov. 2010 Mar;9(3):215-36. Go to original source... Go to PubMed...
    31. Kiki-Mvouaka S, Menez C, Borin C, Lyazrhi F, Foucaud-Vignault M, Dupuy J, Collet X, Alvinerie M, Lespine A. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab Dispos. 2010 Apr;38(4):573-80. Go to original source... Go to PubMed...
    32. Koljonen M, Hakala KS, Ahtola-Satila T, Laitinen L, Kostiainen R, Kotiaho T, Kaukonen AM, Hirvonen J. Evaluation of cocktail approach to standardise Caco-2 permeability experiments. Eur J Pharm Biopharm. 2006 Nov;64(3):379-87. Go to original source...
    33. Lennernas H, Palm K, Fagerholm U, Artursson P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int J Pharm. 1996 Jan 2;127(1):103-7. Go to original source...
    34. Lespine A, Chartier C, Hoste H, Alvinerie M. Endectocides in goats: Pharmacology, efficacy and use conditions in the context of anthelmintics resistance. Small Rumin Res. 2012 Mar;103(1):10-7. Go to original source...
    35. Lespine A, Dupuy J, Alvinerie M, Comera C, Nagy T, Krajcsi P, Orlowski S. Interaction of macrocyclic lactones with the multidrug transporters: The bases of the pharmacokinetics of lipid-like drugs. Curr Drug Metab. 2009 Mar;10(3):272-88. Go to original source... Go to PubMed...
    36. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, Wehling M. Nongenomic steroid action: Controversies, questions, and answers. Physiol Rev. 2003 Jul;83(3):965-1016. Go to original source... Go to PubMed...
    37. McDowell LR. Vitamin nutrition of livestock animals: Overview from vitamin discovery to today. Can J Anim Sci. 2006 Jun;86(2):171-9. Go to original source...
    38. McKellar QA, Gokbulut C. Pharmacokinetic features of the antiparasitic macrocyclic lactones. Curr Pharm Biotechnol. 2012 May;13(6):888-911. Go to original source...
    39. Mealey KL, Owens JG, Freeman E. Canine and feline P-glycoprotein deficiency: What we know and where we need to go. J Vet Pharmacol Ther. 2023 Jan;46(1):1-16. Go to original source... Go to PubMed...
    40. Miller RA, McCluney TS, Halleran JL, Baynes RE, Foster DM. The pharmacokinetics of subcutaneous eprinomectin in plasma and milk in dry dairy cattle. J Vet Pharmacol Ther. 2025 May;48(3):163-9. Go to original source...
    41. Mohammed AA, Ahmed M. Evidence-based veterinary medicine in developing countries: Challenges and opportunities. Acta Vet Eurasia. 2024 Jan;50(1):83-6. Go to original source...
    42. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 2003 Nov;19(11):516-22. Go to original source... Go to PubMed...
    43. Murri S, Knubben-Schweizer G, Torgerson P, Hertzberg H. Frequency of eprinomectin resistance in gastrointestinal nematodes of goats in canton Berne, Switzerland. Vet Parasitol. 2014 Jun 16;203(1-2):114-9. Go to original source... Go to PubMed...
    44. Podszun M, Frank J. Vitamin E-drug interactions: Molecular basis and clinical relevance. Nutr Res Rev. 2014 Dec;27(2):215-31. Go to original source... Go to PubMed...
    45. Radzin S, Wisniewska-Becker A, Markiewicz M, Betkowski S, Furso J, Waresiak J, Grolik J, Sarna T, Pawlak AM. Structural impact of selected retinoids on model photoreceptor membranes. Membranes (Basel). 2023 Jun 1;13(6):575. Go to original source... Go to PubMed...
    46. Rambozzi L, Torsiello B, Formisano R, Pasquetti M, Molinar Min AR, Giammarino M, Battaglini L, Sangrali M, Renna M. Anthelmintic resistance to pour-on eprinomectin against gastrointestinal strongyles and effects on production parameters in early-lactating dairy goats. Vet Sci. 2025 Nov 15;12(11):1088. Go to original source...
    47. Rehbein S, Kellermann M, Wehner TA. Pharmacokinetics and anthelmintic efficacy of topical eprinomectin in goats prevented from grooming. Parasitol Res. 2014 Nov;113(11):4039-44. Go to original source... Go to PubMed...
    48. Reker D, Shi Y, Kirtane AR, Hess K, Zhong GJ, Crane E, Lin CH, Langer R, Traverso G. Machine learning uncovers food- and excipient-drug interactions. Cell Rep. 2020 Mar 17;30(11):3710-6.e4. Go to original source... Go to PubMed...
    49. Renaud D, Holler A, Michel M. Potential drug-nutrient interactions of 45 vitamins, minerals, trace elements, and associated dietary compounds with acetylsalicylic acid and warfarin-a review of the literature. Nutrients. 2024;16(7):950. Go to original source... Go to PubMed...
    50. Rostang A, Devos J, Chartier C. Review of the eprinomectin effective doses required for dairy goats: Where do we go from here? Vet Parasitol. 2020 Jan;277:108992. Go to original source... Go to PubMed...
    51. Sharom FJ. The P-glycoprotein multidrug transporter. Essays Biochem. 2011 Sep 7;50(1):161-78. Go to original source... Go to PubMed...
    52. Stern L, Gwaltney-Brant SM, DeClementi C, Gupta RC. Macrocyclic lactone endectocides. In: Gupta RC, editor. Veterinary toxicology. 4th ed. Amsterdam: Academic Press; 2025. p. 547-62. Go to original source...
    53. Thomas JA. Drug-nutrient interactions. Nutr Rev. 1995 Oct;53(10):271-82. Go to original source... Go to PubMed...
    54. Tolson AH, Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 2010 Oct 30;62(13):1238-49. Go to original source...
    55. Tras B, Uney K, Parlak TM, Tufan O. Vitamins E and A increase the passing of the P-gp substrate ivermectin into the brain in mice. Can J Physiol Pharmacol. 2023 Sep 1;101(9):475-80. Go to original source...
    56. CDER. US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: Food-effect bioavailability and fed bioequivalence studies. Silver Spring (MD): FDA; 2002.
    57. Ustun Alkan F, Anlas C, Cinar S, Yildirim F, Ustuner O, Bakirel T, Gurel A. Effects of curcumin in combination with cyclophosphamide on canine mammary tumour cell lines. Vet Med-Czech. 2014 Nov;59(11):553-60. Go to original source...
    58. Verhoeckx K, Cotter P, Lopez-Exposito I, Kleiveland C, Lea T, Mackie A, Wichers H, editors. The impact of food bioactives on health: In vitro and ex vivo models. Cham: Springer International Publishing; 2015. Go to original source...
    59. Volpe DA, Faustino PJ, Ciavarella AB, Asafu-Adjaye EB, Ellison CD, Yu LX, Hussain AS. Classification of drug permeability with a Caco-2 cell monolayer assay. Clin Res Regul Aff. 2007;24(1):39-47. Go to original source...
    60. Volpe DA. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Future Med Chem. 2011 Dec;3(16):2063-77. Go to original source... Go to PubMed...
    61. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm. 2011 Feb;77(2):275-82. Go to original source... Go to PubMed...
    62. Wang X, Quinn PJ. The location and function of vitamin E in membranes (review). Mol Membr Biol. 2000 Jul-Sep;17(3):143-56. Go to original source... Go to PubMed...
    63. Yang C, Wu T, Qi Y, Zhang Z. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018 Jan 1;8(2):464-85. Go to original source...
    64. Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, Winnike R, Coffin M. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 1999 Dec;16(12):1812-7. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Attribution 4.0 International (CC BY 4.0.), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content